PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,170 stories, page 440 of 687

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07623174: A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07561346: Clinico-pathological and Genomic Features of HER2-low Early Breast Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07494734: MANUAL THERAPY ON PAIN, DISABILITY AND QUALITY OF LIFE

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07391904: Patient-centered Precision Medicine Lab Result Communication for Older Adults

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07370194: Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07244770: The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07227181: Animal Assisted Therapy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07104604: Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07037433: Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06987903: Impact of a Perioperative Physical Exercise and Respiratory Physiotherapy Program on the Patient Undergoing Bariatric Surgery

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06912763: Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06860594: Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06824025: Comparison of Nebulized Neostigmine/Atropine Versus Lignocaine in Treating Acute Post-dural Puncture Headache Following Subarachnoid Block in Parturient Undergoing Elective Cesarean Section. A Randomized, Clinical Trial.

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06411834: Mapping Patient Decision-making in Thyroid Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06316739: The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06193733: Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection - Phase II Clinical Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06066138: A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05657405: Observational Study of Advanced Data Analytics in Genetic Conditions

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05412225: A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04874311: Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04685577: Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04677413: Ultra-fractionated Radiotherapy for Rectal Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04461808: Tomosynthesis as Primary Test for Breast Cancer Screening

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04350138: Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03223753: Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03219359: Autologous Stem Cell Transplant for Crohn's Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02876302: Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01696994: Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00852943: Screening Protocol for Genetic Diseases of Allergic Inflammation

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00004571: Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA panel, with ties to the peptide industry, recommends easing restrictions on four of the compounds

NBC NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Hangzhou Biotest Biotech Co., Ltd. Class A – SSE:688767

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers

Boston HeraldOriginal source
🇺🇰Researchmedsci.ox.ac.ukTier 2 · Direct publisher

First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial

Oxford MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical (WST) Receives Strong Outlook Amidst Quarterly Performance

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sartorius Stedim Biotech SA (SDMHF) Q2 2026 Earnings Call Highli

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Ltd (TEVA) Stock Up 3.4% but GF V

GuruFocusOriginal source
🇺🇰Researchthelancet.comTier 2 · Direct publisher

[Comment] Advancing migraine prevention with comparative evidence

Lancet NeurologyOriginal source
🇺🇰Researchthelancet.comTier 2 · Direct publisher

[Articles] Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial

Lancet NeurologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr.

NBC4 WashingtonOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Virginia Biotech Lab Expands To Support Life Sciences Growth

Business FacilitiesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

Investing News NetworkOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Young Calls for Passage of His Bill to Crack Down on Fraudsters

Senator Young (.gov)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. Q2 2026 Earnings Call Summary

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

'Not scientifically supportable:' Inside FDA’s refusal to face US generic drug crisis

fox23maine.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

'Not scientifically supportable:' Inside FDA’s refusal to face US generic drug crisis

WJLAOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

'Not scientifically supportable:' Inside FDA’s refusal to face US generic drug crisis

WSBTOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech sets Aug. 3 webcast before U.S. markets open

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

'Not scientifically supportable:' Inside FDA’s refusal to face US generic drug crisis

National News DeskOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc 2Q 2026: Revenue $872.3M, EPS $2.15— 10-Q Summary

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[10-Q] WEST PHARMACEUTICAL SERVICES INC Quarterly Earnings Report

Stock TitanOriginal source
🇺🇸Industryir.codexis.comTier 1 · Company source

Codexis Announces Proposed Public Offering of Common Stock

CodexisOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Eli Lilly Reports Positive Results from Two Phase III Trials | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Twin Phase 3 studies recruiting adults with lupus skin problems in US, Canada

Lupus News TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Business WireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharma says sterile packaging upgrades fuel demand for high-value plastics

Plastics NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?

The Globe and MailOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?

The Globe and MailOriginal source